Trial intelligence / Profile preview

Alpha hydroxy acid nanocarrier formulation for plaque psoriasis

PACTR202609884230004Completed

Sponsor
Ahmed Hassan Nouh
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Trial of Glycolic acid and calcipotriol + betamethasone in plaque psoriasis (4 arms), sponsored by Ahmed Hassan Nouh. Primary endpoint: Change in Psoriasis Area and Severity Index (PASI) score. Started Mar 2025; status: completed.

02

Drugs

Glycolic acidcalcipotriol + betamethasone
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on PACTR202609884230004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202609884230004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call